Paradigm Biopharmaceuticals Limited

ASX:PAR 주식 보고서

시가총액: AU$77.1m

Paradigm Biopharmaceuticals 과거 수익 실적

과거 기준 확인 0/6

Paradigm Biopharmaceuticals's earnings have been declining at an average annual rate of -29.1%, while the Biotechs industry saw earnings growing at 12.6% annually. Revenues have been declining at an average rate of 73.9% per year.

주요 정보

-29.1%

수익 성장률

-19.5%

EPS 성장률

Biotechs 산업 성장9.6%
매출 성장률-73.9%
자기자본 수익률-246.4%
순이익n/a
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Paradigm Biopharmaceuticals (ASX:PAR) Is In A Strong Position To Grow Its Business

Aug 22
Paradigm Biopharmaceuticals (ASX:PAR) Is In A Strong Position To Grow Its Business

Here's Why We're Not At All Concerned With Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

Apr 17
Here's Why We're Not At All Concerned With Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Sep 21
Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

Jun 20
Here's Why We're Not Too Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Dec 02
Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Jun 07
Companies Like Paradigm Biopharmaceuticals (ASX:PAR) Are In A Position To Invest In Growth

Is Paradigm Biopharmaceuticals Limited (ASX:PAR) Trading At A 46% Discount?

Feb 22
Is Paradigm Biopharmaceuticals Limited (ASX:PAR) Trading At A 46% Discount?

We're Not Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn

Jan 24
We're Not Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn

Did You Participate In Any Of Paradigm Biopharmaceuticals' (ASX:PAR) Incredible 811% Return?

Dec 28
Did You Participate In Any Of Paradigm Biopharmaceuticals' (ASX:PAR) Incredible 811% Return?

When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit?

Nov 29
When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit?

수익 및 비용 분석

Paradigm Biopharmaceuticals 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

ASX:PAR 수익, 비용 및 수입 (AUD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 240-59758
31 Mar 240-64665
31 Dec 230-69671
30 Sep 230-60762
30 Jun 230-52753
31 Mar 230-48948
31 Dec 220-441043
30 Sep 220-42941
30 Jun 220-39939
31 Mar 220-40939
31 Dec 210-411040
30 Sep 210-371037
30 Jun 210-341034
31 Mar 210-31730
31 Dec 20-1-28527
30 Sep 200-20420
30 Jun 200-12314
31 Mar 202-14412
31 Dec 194-1649
30 Sep 193-1648
30 Jun 193-1648
31 Mar 193-1137
31 Dec 183-737
30 Sep 183-727
30 Jun 183-627
31 Mar 182-626
31 Dec 172-525
30 Sep 172-525
30 Jun 172-424
31 Mar 172-424
31 Dec 161-424
30 Sep 161-423
30 Jun 161-313
31 Mar 161-322
31 Dec 150-211
30 Sep 150-211
30 Jun 150-210

양질의 수익: PAR is currently unprofitable.

이익 마진 증가: PAR is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: PAR is unprofitable, and losses have increased over the past 5 years at a rate of 29.1% per year.

성장 가속화: Unable to compare PAR's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: PAR is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (2.5%).


자기자본 수익률

높은 ROE: PAR has a negative Return on Equity (-246.38%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기